Clever Leaves Reports Fourth Quarter and Full Year 2022 Results
Retrieved on:
Thursday, March 30, 2023
Leaf, Insurance, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., High-quality feed block, Hard Drive Productions, Inc. v. Does 1–1,495, Marketing, Gateway Group, Calendar, G&A, Economics, Sale, Convertible, Public expenditure, Traction, EBITDA, Acquisition, Cannabis, Growth, Staff, API, Video game, Renewable energy, Pharmaceutical industry, Cryptocurrency, Health care, Beauty salon, Legume, Airline, Floral industry, Drug, Auction
TOCANCIPÁ, Colombia, March 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2022. All financial information is provided in US dollars unless otherwise indicated.
Key Points:
- “2022 was a transformational year for Clever Leaves as we executed on our refined growth strategy,” said Andres Fajardo, CEO of Clever Leaves.
- Operating expenses in the fourth quarter of 2022 were $29.5 million compared to $29.9 million for the same period in 2021.
- Adjusted EBITDA in the fourth quarter of 2022 was $(5.2) million compared to $(6.6) million for the same period in 2021.
- Clever Leaves will conduct a conference call today at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2022.